89bio presents additional exploratory analyses from the phase 1b/2a nash study of pegozafermin at aasld the liver meeting® 2022

- new analysis of cohort 7 data using a three-reader pathologist panel showed that 6/19 patients scored as having fibrosis stage 4 at baseline (putative f4); excluding these patients resulted in higher histological response rates in the patients with f2-f3 fibrosis than previously reported -
ETNB Ratings Summary
ETNB Quant Ranking